FAM237A , rather than peptide PEN and proCCK56 ‐63, binds to and activates the orphan receptor GPR83
The FEBS Journal · 2023
DOI: 10.1111/febs.16765 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2023. Verfasst von Hao-Zheng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Neuropeptides. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
G protein‐coupled receptor 83 (GPR83) is primarily expressed in the brain and is implicated in the regulation of energy metabolism and some anxiety‐related behaviours. Recently, the PCSK1N/proSAAS‐derived peptide PEN, the procholecystokinin‐derived peptide proCCK56‐63, and family with sequence similarity 237 member A (FAM237A) were all reported as efficient agonists of GPR83. However, these results have not yet been reproduced by other laboratories and thus GPR83 is still officially an orphan receptor. The peptide PEN and proCCK56‐63 share sequence similarity; however, they are completely different from FAM237A. To identify its actual ligand(s), in the present study we developed NanoLuc Binary Technology (NanoBiT)‐based ligand‐binding assay, fluorescent ligand‐based visualization, and NanoBiT‐based β‐arrestin recruitment assay for human GPR83. Using these assays, we demonstrated that mature human FAM237A could bind to GPR83 with nanomolar range affinity, and could activate this receptor and induce its internalization with nanomolar range efficiency in transfected human embryonic kidney 293T cells. However, we did not detect any interaction of PEN and proCCK56‐63 with GPR83 using these assays. Thus, our results confirmed that FAM237A is an efficient agonist of GPR83, but did not support PEN and proCCK56‐63 as ligands of this receptor. Clarification of their pairing paves the way for further functional studies of the brain‐specific receptor GPR83 and the so far rarely studied neuropeptide FAM237A in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
ORCID-Profile: Zhan-Yun Guo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, H. Z., Wang, Y. F., Shao, X. X., Liu, Y. L., Xu, Z. G., Wang, S. L., & Guo, Z. Y. (2023). FAM237A , rather than peptide PEN and proCCK56 ‐63, binds to and activates the orphan receptor GPR83. The FEBS Journal. https://doi.org/10.1111/febs.16765
Vancouver
Li HZ, Wang YF, Shao XX, Liu YL, Xu ZG, Wang SL, et al. FAM237A , rather than peptide PEN and proCCK56 ‐63, binds to and activates the orphan receptor GPR83. The FEBS Journal. 2023. doi:10.1111/febs.16765
BibTeX
@article{Li2023,
author = {Li, Hao-Zheng and Wang, Ya-Fen and Shao, Xiao-Xia and Liu, Ya-Li and Xu, Zeng-Guang and Wang, Shi-Long and Guo, Zhan-Yun},
title = {FAM237A , rather than peptide PEN and proCCK56 ‐63, binds to and activates the orphan receptor GPR83},
journal = {The FEBS Journal},
year = {2023},
doi = {10.1111/febs.16765}
}
EUVIMED